Informativa e consenso per l'uso dei cookie

Accetto Il nostro sito salva piccoli pezzi di informazioni (cookie) sul dispositivo, al fine di fornire contenuti migliori e per scopi statistici. È possibile disattivare l'utilizzo di cookies modificando le impostazioni del tuo browser. Continuando la navigazione si acconsente all'utilizzo dei cookie.

54965-24-1 - Tamoxifen citrate - cis-1-(4-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene citrate - J60955 - Alfa Aesar

J60955 Tamoxifen citrate

Codice CAS
54965-24-1
Sinonimi
cis-1-(4-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene citrate

Dimensioni Prezzo ($) Quantità Disponibilità
1g 192,61
5g 468,00
Aggiungi al carrello Aggiungi al preventivo generale Visualizza articolo

Tamoxifen citrate

MDL
MFCD00058321
EINECS
259-415-2

Proprietà chimiche

Formula
C26H29NO.C6H8O7
Peso formula
563.65
Modulo
White to off-white powder
Sensibilità
Light Sensitive & Hygroscopic
Solubilità
Soluble in methanol (50 mg/ml with heat) or ethanol (10 mg/ml with sonication); very slightly soluble in water (0.3 mg/L @ 20°C; the pH is approximately 3.0-3.5), 0.02 N HCl (0.2 mg/ml @ 37°C)4, acetone ,chloroform,and DMSO(100mM)

Applicazioni

Tamoxifen citrate is used as an antiestrogen with potent anti-cancer and PKC inhibitory activities. Tamoxifen Citrate functions as an estrogen receptor antagonist in breast tissue. Tamoxifen Citrate is an agonist towards this receptor in tissues of the endometrium. Tamoxifen Citrate inhibits DNA synthesis and transcription by recruiting co-repressors, which stop estrogen from interacting with genes. When combined with PAX2, Tamoxifen Citrate can inhibit the proliferation of ERBB2. It is also a high affinity activator of the GPR30 receptor. Tamoxifen Citrate is an activator of Estrogen Receptor.

Note

Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature: 2 - 8°C. Keep away from strong oxidizing agents.

Letteratura

Wakeling et al. Non-steroidal anti-estrogens - receptor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cells. J.Steroid.Biochem. 1984, 20,(1), 111-20.

Paul et al. Both the immunosuppressant SR31747 and the antioestrogen tamoxifen bind to an emopamil-insensitive site of mammalian Δ8-Δ7 sterol isomerase. J.Pharmacol.Exp.Ther. 1998, 285,(3), 1296-302.

Rischio GHS e dichiarazioni precauzionali

Dichiarazioni di rischio (UE): H350-H360-H362-H302

May cause cancer. May damage fertility or the unborn child. May cause harm to breast-fed children. Harmful if swallowed.

Dichiarazioni precauzionali: P263-P260-P201-P281-P264-P270-P301+P312-P308+P313-P405-P501a

Avoid contact during pregnancy/while nursing. Do not breathe dust/fume/gas/mist/vapours/spray. Obtain special instructions before use. Use personal protective equipment as required. Wash thoroughly after handling. Do not eat, drink or smoke when using this product. IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell. IF exposed or concerned: Get medical advice/attention. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.

Altri riferimenti

Merck
14,9048
Codice tariffe armonizzato
2922.29
TSCA
No
RTECS
KH2387000

Raccomandato

Visualizzati di recente

Prodotti chimici

Scienze della vita

Metalli e materiali

Catalizzatori

Apparecchiature di analisi e di laboratorio